Skip to main content

Table 2 Baseline characteristics of included participants

From: Brain magnetic resonance imaging in imported malaria

N 17
Male sex, n (%) 14 (82%)
Age, years 49 (20–64)
Visiting friends and relatives, n(%) 8 (47%)
Percentage of infected erythrocytes 1% (0.1–40%)
Patients with complicated malaria, n (%) 5 (31%)
 Hyperparasitaemia (> 10%) 4
 Shock, needing vasopressor support 1
 Spontaneous bleeding 1
 Haemoglobinuria 1
 Acute kidney injury 1
GCS at presentation (median, range) 15 (12–15)
Neurological symptoms at presentation, n(%)
 Headaches 7 (41%)
 Aphasia 2 (12%)
 Disorientation 2 (12%)
 Somnolence 1 (6%)
Haemoglobin at presentation, g/dl 13.1 (10.3–15.7)
White blood count at presentation, /µl 4.8 (3.7–10.3)
Thrombocyte count at presentation, /µl 61 (11–209)
Treatment regimens, n (%)
 Artesunate, followed by Atovaquone/proguanil 5 (29%)
 Dihydroartemisinin/piperaquine 6 (35%)
 Atovaquone/proguanil 5 (29%)
 Mefloquine 1 (6%)
  1. Values represent median and range, unless otherwise specified